Need help? Talk to our expert.
WhatsApp

NextGen BRCA Somatic, FFPE tissue
₹ 22,000
NextGen BRCA Somatic, FFPE tissue
₹ 22,000
51+ booked in last 3 days

NextGen BRCA Somatic, FFPE tissue

Also Known As :

Report
Report 16th day
Fasting
Fasting no
Recommended for
Recommended for Male, Female
NextGen BRCA Somatic Mutation Analysis, FFPE Tissue
₹ 22,000

Next-generation sequencing (NextGen) of BRCA somatic mutations in formalin-fixed paraffin-embedded (FFPE) tissue samples plays a pivotal role in identifying specific genetic alterations within the BRCA genes. This molecular analysis is particularly relevant in the context of PARP inhibitor therapy. PARP inhibitors are a class of targeted cancer treatments that show effectiveness in patients with BRCA mutations, as these mutations impair DNA repair mechanisms. By assessing somatic mutations in the BRCA genes using NextGen sequencing on FFPE tissue samples, healthcare providers can identify actionable genetic changes that inform the use of PARP inhibitor therapies. This personalized approach enhances treatment decisions and potentially improves outcomes for individuals with cancers linked to BRCA mutations.

Frequently asked questions

Find quick answers to the most common questions about health tests, bookings, and reports.

This test measures specific genetic mutations in the BRCA genes. Mutations in these genes increase the risk of developing certain types of cancer, particularly breast and ovarian cancer.

• To identify mutations in the BRCA genes that may increase the risk of developing certain types of cancer

• To determine eligibility for targeted therapies, such as PARP inhibitor therapy

• To assess the response to treatment in patients receiving PARP inhibitor therapy

• To provide a personalised risk assessment for individuals with a family history of breast or ovarian cancer

This test is recommended for individuals who

  •  have a personal or family history of breast or ovarian cancer,
  •  have already been diagnosed with breast or ovarian cancer and want to determine if they have an inherited mutation,
  • are considering or undergoing targeted therapies, such as PARP inhibitor therapy, or
  • have a family member with a known BRCA mutation.

Abnormal results may indicate the presence of specific genetic mutations that increase the risk of developing certain types of cancer.

Book a Home Visit Now

Book any blood test or health checkup and get tested at the comfort of your home.

Why Metropolis Healthcare?

With 45 years of diagnostic excellence, Metropolis Healthcare has built a trusted, science led diagnostics network supported by advanced laboratory infrastructure, rigorous quality standards and deep clinical expertise.

Our capabilities span routine, specialised and super-specialised diagnostics, including molecular diagnostics, genomics, cytogenetics, oncology, neurology, nephrology, women and child health, and other advanced areas. By combining scientific expertise, technology and a strong focus on quality, we deliver precise and reliable diagnostic insights that support better-informed healthcare decisions.

NABL & CAP

Accredited labs

Advanced Labs

210+

Clinical Labs

Trusted by

750+ Towns

Pan India Presence

Scientific Officers

2,000+

Scientific Team Members

Proficiency Testing

4,500+

Test & Profiles

Latest Blogs & News

Stay informed with our expert insights and updates.

About Us

Metropolis Healthcare is one of India’s leading diagnostics companies, with 45 years of experience built on scientific expertise, quality and trust. We serve millions of patients through a growing network supported by advanced laboratory infrastructure, technology and a patient-first approach. Our comprehensive portfolio includes 4,500+ tests and profiles across routine, specialised and super-specialised diagnostics, spanning pathology, molecular diagnostics, genomics, cytogenetics, oncology, neurology, nephrology, women and child health, preventive healthcare and wellness.

With 210+ clinical laboratories and a service network of 5,000+ touchpoints reaching more than 750 towns in India, we are focused on making trusted diagnostic services more accessible while maintaining rigorous quality standards. By combining scientific excellence, advanced technology and human expertise, we deliver accurate, reliable and relevant diagnostic insights that support better-informed healthcare decisions.

To book your home visit call us at 080-4891-1400

Book a Home Visit Now!

080-4891-1400
Proceed